2,3,3',4,4',5-hexachlorobiphenyl has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, N; Gu, J; Liu, W; Qi, Y; Shan, Q; Tan, X | 1 |
| Chen, A; Chen, N; Liu, W; Qu, F; Shan, Q | 1 |
2 other study(ies) available for 2,3,3',4,4',5-hexachlorobiphenyl and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Transcriptome analysis in normal human liver cells exposed to 2, 3, 3', 4, 4', 5 - Hexachlorobiphenyl (PCB 156).
Topics: Aldehyde Dehydrogenase; Cell Line; Cholesterol; Cytochrome P-450 CYP1B1; Edar Receptor; Gene Expression Profiling; Humans; Liver; Non-alcoholic Fatty Liver Disease; Oligonucleotide Array Sequence Analysis; Polychlorinated Biphenyls; RNA, Long Noncoding; RNA, Messenger; Toxicity Tests; Transcriptome; Triglycerides | 2020 |
Exposure to 2,3,3',4,4',5-hexachlorobiphenyl promotes nonalcoholic fatty liver disease development in C57BL/6 mice.
Topics: Animals; Diet, High-Fat; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Polychlorinated Biphenyls | 2020 |